With its unique ability to stimulate lipolysis and inhibit lipogenesis, AOD-9604 is ideal for those individuals who have discontinued GLP-1 therapy
A temporary feeling of warmth in the area
The Mechanism of Action of AOD9604 AOD9604 primarily acts on adipose tissue (fat cells) through a specific mechanism: Targeted Lipolysis: Research suggests that AOD9604 stimulates the breakdown of stored fat (lipolysis) and inhibits lipogenesis (the formation of new fat), particularly in overweight individuals

What CPT 96372 Includes: Drawing up and preparing the medication for injection Administering the injection at the specified anatomical site Immediate pre-injection patient assessment Post-injection monitoring for adverse reactions Provider or supervised staff time and clinical expertise What CPT 96372 Excludes: The cost of the drug or substance injected (bill via J-code) Evaluation and management services (bill separately with correct modifier) Vaccine administration (use the 90471 series instead) Chemotherapy drug delivery (use 96401 or 96402) Intravenous push or infusion (use 96374 or 96365 and above) Intra-articular joint injections (use 20600 to 20611) Self-administered medications Understanding this boundary matters every single time you build a claim
For example, some patients may need a medication in liquid form when the FDA-approved drug comes in a pill
It does not describe effects in humans, is not medical or health advice, and this product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or condition